Importantly, knockdown of BTG1 in GD2‐CAR.15 NKTs led to the elimination of metastatic neuroblastoma in a preclinical mouse model, suggesting a potential strategy for enhancing the anti‐tumor efficacy of this therapy. Here, BTG1 is linked to neuroblastoma.